Behavioral and neural effects of nicotine on visuospatial attentional reorienting in non-smoking subjects.
The cholinergic neurotransmitter system has been proposed to be involved in the processing of probabilistic top-down information provided by endogenous cues in location-cueing paradigms. It has been shown that the behavioral and neural effects of a nicotinic cholinergic stimulation resemble the effects obtained by manipulating the validity of the spatial cues: enhancing cortical nicotine levels and decreasing cue validity both reduce the reaction time difference between invalidly and validly cued targets (ie, the 'validity effect') as well as neural activity related to attentional reorienting in parietal brain regions. In the present study, we investigated whether the behavioral and neural effects of nicotine in location-cueing paradigms are dependent upon different a priori cue validities. Twenty-four subjects were investigated in a double-blind placebo-controlled between-subject design with functional magnetic resonance imaging. Nicotine was administered to non-smoking volunteers via polacrilex gums (Nicorette, 2 mg) before performing a location-cueing paradigm with valid and invalid cues in the context of 90 and 60% cue validity in the MR scanner. Nicotine significantly reduced the validity effect in the 90% but not in the 60% cue validity condition. Fronto-parietal and cingulate regions showed stronger nicotinic reductions of reorienting-related neural activity in the high than in the low cue validity condition. Our data reveal an interaction effect between the pharmacological and cognitive modulation of attentional reorienting, which is evident at both a behavioral as well as the neuronal level.
Vossel
Simone
S
Department of Medicine, Institute of Neuroscience and Biophysics, Research Centre Jülich, Jülich, Germany. s.vossel@fz-juelich.de
Thiel
Christiane M
CM
Fink
Gereon R
GR
D000328:Adult; D000704:Analysis of Variance; D001288:Attention / Q000187:drug effects*; D001931:Brain Mapping; D003463:Cues; D004311:Double-Blind Method; D005133:Eye Movements; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D009538:Nicotine / Q000494:pharmacology*; D018722:Nicotinic Agonists / Q000494:pharmacology*; D010100:Oxygen / Q000097:blood; D010775:Photic Stimulation / Q000379:methods; D011930:Reaction Time / Q000187:drug effects* / Q000502:physiology; D013028:Space Perception / Q000187:drug effects*; D014793:Visual Cortex / Q000098:blood supply / Q000187:drug effects*
D018722:Nicotinic Agonists; D009538:Nicotine; D010100:Oxygen